Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nello Mainolfi Insider Profile
4 Followers
Nello Mainolfi, CEO, Director at Kymera Therapeutics, holds 615.57K shares in Kymera Therapeutics (Ticker: KYMR). Most recently, Nello Mainolfi Bought $9,000 shares of Kymera Therapeutics on Jan 02, 2024 for an estimated value of 18.72K.
Nello Mainolfi Kymera Therapeutics (KYMR)CEO, Director
Kymera Therapeutics (KYMR)
CEO, Director
Ranked #55,448 out of 98,909 Corporate Insiders
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
-2.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Nello Mainolfi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nello Mainolfi
Nello Mainolfi's Trading History
List of latest transactions for each holding click on a transaction to see Nello Mainolfi's performance on stock
You May Also Like
Nello Mainolfi insider profile FAQ
What is the percentage of profitable transactions made by Nello Mainolfi?
The percentage of profitable transactions made by Nello Mainolfi is 40%.
What is the average return per transaction made by Nello Mainolfi?
The average return per transaction made by Nello Mainolfi is -2.00%.
What stocks does Nello Mainolfi hold?
Nello Mainolfi holds: KYMR stocks.
What was Nello Mainolfi’s latest transaction?
Nello Mainolfi latest transaction was an Informative Buy of $18.72K.
What was Nello Mainolfi's most profitable transaction?
Nello Mainolfi’s most profitable transaction was an Informative Buy of KYMR stock on November 6, 2023. The return on the trade was 163.10%.
What is Nello Mainolfi's role in Kymera Therapeutics?
Nello Mainolfi's role in Kymera Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.